Enhanced Expression and Purification Strategy for Recombinant Bacterially-Expressed Human Hexokinase II

Dengue virus hijacks the host cellular mechanism to propagate and survive during viral infection, in which the central carbon mechanism plays a crucial role to upregulate DENV infection through the increase of human hexokinase II (HKII) activity. Since the enzyme governs the glycolytic pathway, it h...

Full description

Bibliographic Details
Main Authors: Fazia Adyani Ahmad Fuad, Suriyea Tanbin
Format: Article
Language:English
Published: Jenderal Soedirman University 2021-03-01
Series:Molekul
Online Access:https://ojs.jmolekul.com/ojs/index.php/jm/article/view/709
_version_ 1818440768712343552
author Fazia Adyani Ahmad Fuad
Suriyea Tanbin
author_facet Fazia Adyani Ahmad Fuad
Suriyea Tanbin
author_sort Fazia Adyani Ahmad Fuad
collection DOAJ
description Dengue virus hijacks the host cellular mechanism to propagate and survive during viral infection, in which the central carbon mechanism plays a crucial role to upregulate DENV infection through the increase of human hexokinase II (HKII) activity. Since the enzyme governs the glycolytic pathway, it has potentials as a target for anti-dengue (DENV) drug development. In this study, the production of human hexokinase II protein has been enhanced by using bacterial system for anti-dengue therapeutic purpose. The HKII gene was cloned into pET28b vector and transformed into the E. coli strain BL21 (DE3) for HKII expression. In order to obtain soluble recombinant HKII in an active form, we optimized protein expression under specific conditions at 18°C for 19 hours using Terrific Broth media, in the presence of 0.5 mM isopropyl-2-D-thiogalactopyranoside (IPTG). The pET28b-HKII construct expressed in BL21(DE3) system exhibited adequate protein expression, thus, this construct was subsequently proceeded to purification process. The expressed protein was purified to homogeneity by a combination of Immobilized Metal Ion Affinity Chromatography (IMAC)and size exclusion chromatography (SEC), resulting in pure, active bacterially-expressed HKII with a specific activity of 56. 67U.mg-1. The amount of HKII obtained from 2 L culture is 80 mg, with a yield percentage of 10.5%.  Hence in this study, human HKII has successfully been cloned and expressed as a soluble protein that can be utilized for further therapeutic studies.
first_indexed 2024-12-14T18:17:37Z
format Article
id doaj.art-88e76041b6f545e68ea8661e1045cc12
institution Directory Open Access Journal
issn 1907-9761
2503-0310
language English
last_indexed 2024-12-14T18:17:37Z
publishDate 2021-03-01
publisher Jenderal Soedirman University
record_format Article
series Molekul
spelling doaj.art-88e76041b6f545e68ea8661e1045cc122022-12-21T22:52:09ZengJenderal Soedirman UniversityMolekul1907-97612503-03102021-03-01161829110.20884/1.jm.2021.16.1.709328Enhanced Expression and Purification Strategy for Recombinant Bacterially-Expressed Human Hexokinase IIFazia Adyani Ahmad Fuad0Suriyea Tanbin1Department of Biotechnology Engineering, Faculty of Engineering, International Islamic University MalaysiaDepartment of Biotechnology Engineering, Faculty of Engineering, International Islamic University MalaysiaDengue virus hijacks the host cellular mechanism to propagate and survive during viral infection, in which the central carbon mechanism plays a crucial role to upregulate DENV infection through the increase of human hexokinase II (HKII) activity. Since the enzyme governs the glycolytic pathway, it has potentials as a target for anti-dengue (DENV) drug development. In this study, the production of human hexokinase II protein has been enhanced by using bacterial system for anti-dengue therapeutic purpose. The HKII gene was cloned into pET28b vector and transformed into the E. coli strain BL21 (DE3) for HKII expression. In order to obtain soluble recombinant HKII in an active form, we optimized protein expression under specific conditions at 18°C for 19 hours using Terrific Broth media, in the presence of 0.5 mM isopropyl-2-D-thiogalactopyranoside (IPTG). The pET28b-HKII construct expressed in BL21(DE3) system exhibited adequate protein expression, thus, this construct was subsequently proceeded to purification process. The expressed protein was purified to homogeneity by a combination of Immobilized Metal Ion Affinity Chromatography (IMAC)and size exclusion chromatography (SEC), resulting in pure, active bacterially-expressed HKII with a specific activity of 56. 67U.mg-1. The amount of HKII obtained from 2 L culture is 80 mg, with a yield percentage of 10.5%.  Hence in this study, human HKII has successfully been cloned and expressed as a soluble protein that can be utilized for further therapeutic studies.https://ojs.jmolekul.com/ojs/index.php/jm/article/view/709
spellingShingle Fazia Adyani Ahmad Fuad
Suriyea Tanbin
Enhanced Expression and Purification Strategy for Recombinant Bacterially-Expressed Human Hexokinase II
Molekul
title Enhanced Expression and Purification Strategy for Recombinant Bacterially-Expressed Human Hexokinase II
title_full Enhanced Expression and Purification Strategy for Recombinant Bacterially-Expressed Human Hexokinase II
title_fullStr Enhanced Expression and Purification Strategy for Recombinant Bacterially-Expressed Human Hexokinase II
title_full_unstemmed Enhanced Expression and Purification Strategy for Recombinant Bacterially-Expressed Human Hexokinase II
title_short Enhanced Expression and Purification Strategy for Recombinant Bacterially-Expressed Human Hexokinase II
title_sort enhanced expression and purification strategy for recombinant bacterially expressed human hexokinase ii
url https://ojs.jmolekul.com/ojs/index.php/jm/article/view/709
work_keys_str_mv AT faziaadyaniahmadfuad enhancedexpressionandpurificationstrategyforrecombinantbacteriallyexpressedhumanhexokinaseii
AT suriyeatanbin enhancedexpressionandpurificationstrategyforrecombinantbacteriallyexpressedhumanhexokinaseii